Literature DB >> 25941790

Prostate cancer: Can imaging accurately diagnose lymph node involvement?

Jelle O Barentsz1, Harriet C Thoeny2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25941790     DOI： 10.1038/nrurol.2015.91

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.

Authors:  Roel A M Heesakkers; Anke M Hövels; Gerrit J Jager; Harrie C M van den Bosch; J Alfred Witjes; Hein P J Raat; Johan L Severens; Eddy M M Adang; Christina Hulsbergen van der Kaa; Jurgen J Fütterer; Jelle Barentsz
Journal:  Lancet Oncol       Date:  2008-08-15       Impact factor: 41.316

2.  Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients.

Authors:  Hanneke J M Meijer; Ansje S Fortuin; Emile N J T van Lin; Oscar A Debats; J Alfred Witjes; Johannes H A M Kaanders; Jelle O Barentsz
Journal:  Radiother Oncol       Date:  2012-11-27       Impact factor: 6.280

3.  Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.

Authors:  Chung Yao Yu; Bhushan Desai; Lingyun Ji; Susan Groshen; Hossein Jadvar
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

4.  Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.

Authors:  Ansje S Fortuin; Willem M L L G Deserno; Hanneke J M Meijer; Gerrit J Jager; Satoru Takahashi; Oscar A Debats; Sven N Reske; Christian Schick; Bernd J Krause; Inge van Oort; Alfred J Witjes; Yvonne L Hoogeveen; Emile N J Th van Lin; Jelle O Barentsz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-13       Impact factor: 7.038

5.  Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.

Authors:  Laura Van den Bergh; Evelyne Lerut; Karin Haustermans; Christophe M Deroose; Raymond Oyen; Sofie Isebaert; Tom Budiharto; Filip Ameye; Felix M Mottaghy; Kris Bogaerts; Hendrik Van Poppel; Steven Joniau
Journal:  Urol Oncol       Date:  2015-02-02       Impact factor: 3.498

6.  Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.

Authors:  Roel A M Heesakkers; Gerrit J Jager; Anke M Hövels; Bartjan de Hoop; Harrie C M van den Bosch; Frank Raat; J Alfred Witjes; Peter F A Mulders; Christina Hulsbergen van der Kaa; Jelle O Barentsz
Journal:  Radiology       Date:  2009-05       Impact factor: 11.105

7.  Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.

Authors:  Frédéric D Birkhäuser; Urs E Studer; Johannes M Froehlich; Maria Triantafyllou; Lauren J Bains; Giuseppe Petralia; Peter Vermathen; Achim Fleischmann; Harriet C Thoeny
Journal:  Eur Urol       Date:  2013-07-30       Impact factor: 20.096

8.  Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.

Authors:  Harriet C Thoeny; Johannes M Froehlich; Maria Triantafyllou; Juerg Huesler; Lauren J Bains; Peter Vermathen; Achim Fleischmann; Urs E Studer
Journal:  Radiology       Date:  2014-06-02       Impact factor: 11.105

Review 9.  The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.

Authors:  A M Hövels; R A M Heesakkers; E M Adang; G J Jager; S Strum; Y L Hoogeveen; J L Severens; J O Barentsz
Journal:  Clin Radiol       Date:  2008-02-04       Impact factor: 2.350

10.  Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Authors:  Ali Afshar-Oromieh; Christian M Zechmann; Anna Malcher; Matthias Eder; Michael Eisenhut; Heinz G Linhart; Tim Holland-Letz; Boris A Hadaschik; Frederik L Giesel; Jürgen Debus; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-27       Impact factor: 9.236
  10 in total
  3 in total

1.  [PI-RADS 2.0 for Prostate MRI].

Authors:  T Franiel; M Röthke
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

Review 2.  PET imaging for lymph node dissection in prostate cancer.

Authors:  Elena Incerti; Paola Mapelli; Luigi Gianolli; Maria Picchio
Journal:  World J Urol       Date:  2016-10-17       Impact factor: 4.226

3.  Invited Commentary on "Molecular Imaging of Prostate Cancer".

Authors:  Peter L Choyke
Journal:  Radiographics       Date:  2015-11-20       Impact factor: 5.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.